( May 14, 2026, 7:38 AM EDT) -- Attorneys general from North Carolina and Maryland announced separate settlement agreements reached with Mylan Inc. to resolve claims that the seller of the EpiPen epinephrine autoinjector (EAI) used anticompetitive tactics to keep generic versions of the EpiPen off the market and artificially increased the cost of its life-saving device...